title: Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel.
abstract: Faropenem was tested against 1,188 middle ear fluid pathogens from children in Israel and Costa Rica. Against Streptococcus pneumoniae and Haemophilus influenzae, faropenem was the most active beta-lactam, with activity that was similar to or greater than of the other oral antimicrobial classes studied. Faropenem was also active against Moraxella catarrhalis and Streptococcus pyogenes.
authors: Replidyne Inc., 1450 Infinite Drive, Louisville, CO 80027, USA.
authors: Kimberley Clawson
authors: KC
authors: Stone
authors: Ron
authors: R
authors: Dagan
authors: Adriano
authors: A
authors: Arguedas
authors: Eugene
authors: E
authors: Leibovitz
authors: Elaine
authors: E
authors: Wang
authors: Roger M
authors: RM
authors: Echols
authors: Nebojsa
authors: N
authors: Janjic
authors: Ian A
authors: IA
authors: Critchley
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D003364:Costa Rica; D004432:Ear, Middle / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000187:drug effects*; D006801:Humans; D007557:Israel; D008826:Microbial Sensitivity Tests / Q000379:methods; D001936:Moraxella catarrhalis / Q000187:drug effects; D010034:Otitis Media with Effusion / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D013297:Streptococcus pyogenes / Q000187:drug effects; D047090:beta-Lactams / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams; C107057:fropenem